Comments
SXC to buy Catalyst in $4.4 billion drug benefit deal
19.04.2012. | (Reuters) - SXC Health Solutions Corp said it will buy rival pharmacy benefit manager Catalyst Health Solutions Inc for $4.4 billion as it seeks to keep pace in the rapidly consolidating market for managing Americans' prescriptions....
